Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
about
Improving Vaccine and Immunotherapy Design Using Biomaterials.Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors.Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy.Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions.
P2860
Q47676665-B71FE5DE-BDA7-4A65-A06D-0B2473402031Q49401353-852973FA-2E68-4AC0-88BC-E40F2CA30704Q49795880-DDD8C911-43B3-4714-B951-5B9342400778Q50080885-8287C9AA-A4F3-4341-B80F-80FC79032492Q50426810-09B2DDF5-0002-49C4-8391-684E2807105EQ55007922-41F1C66E-FF62-4022-A56E-E6CBBDC4974EQ55287125-CDDAF170-2278-46E7-963A-FB0066FC7970
P2860
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@en
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@nl
type
label
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@en
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@nl
prefLabel
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@en
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.
@nl
P2093
P2860
P50
P356
P1476
Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy
@en
P2093
Christina A von Roemeling
Hengfeng Yuan
Keith L Knutson
Kyuson Yun
Robert E Wharen
Xiujie Liu
Yaqing Qie
Yuanxin Chen
P2860
P2888
P304
P356
10.1038/NNANO.2017.69
P577
2017-05-01T00:00:00Z